Nfl Biosciences
Business Services · France · 1-10 Employees
View Company Info for Free
Overview
Headquarters
199 Rue Hélène Boucher, Castelnau-le-Lez...Phone Number
+33 411937667Website
www.nflbiosciences.comRevenue
-Stock Symbol
ALNFLIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Nfl Biosciences
NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. The company's natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stageExplore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nfl Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Nfl Biosciences has new funding data
Website visits: Recent activity has been detected on your website
Check out if Nfl Biosciences is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Nfl Biosciences
Nfl Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Nfl Biosciences recently announced quarterly report
Check if Nfl Biosciences has recently received funding, and reach out quickly before it becomes old news!
Click to see if Nfl Biosciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Nfl Biosciences launches new products
Recommended Actions
Reach out to Masked Content who joined Nfl Biosciences as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Nfl Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nfl Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nfl Biosciences.
Nfl Biosciences financials insights
Gather financial insights about Nfl Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Share Placement
$2.7M
Other Financing Round
$633K
2025
Stock/Share Issuance
$3.4M
Debt
$1.2M
Nfl Biosciences Tech Stack
A closer look at the technologies used by Nfl Biosciences
Most Recent Scoops
Person-Based
Events
Funding
Funding
Funding
Funding
Executive Move
Board of Directors
Executive Move
Board of Directors
Nfl Biosciences News & Media
NFL BIOSCIENCES: GB HOLDING TAKES A STAKE IN THE COMPANY'S - GlobeNewswire
NFL BIOSCIENCES: GB HOLDING TAKES A STAKE IN THE COMPANY’S CAPITAL UPON THE EXERCISE OF SHARE SUBSCRIPTION WARRANTS AND PAYMENT OF 0.5M€, AND ALSO COMMITS...NFL BIOSCIENCES: Approval for its patent to be granted on NFL-101 in Europe and approval of the clinical development plan for NFL-101 by the EMA
NFL BIOSCIENCES: Approval for its patent to be granted on NFL-101 in Europe and approval of the clinical development plan for NFL-101 by the EMANFL Biosciences: Recruitment completed for the PRECESTO study
NFL Biosciences: Recruitment completed for the PRECESTO studyNFL Biosciences: 2022 full-year business and earnings update
NFL Biosciences: 2022 full-year business and earnings update
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nfl Biosciences
Sign Up For FreeTo access detailed company insights
NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. The company's natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stag... Read More
